These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11879716)

  • 1. Sudden onset of diabetes with ketoacidosis in a patient treated with FK506/tacrolimus.
    Toyonaga T; Kondo T; Miyamura N; Sekigami T; Sonoda K; Kodama S; Shirakami A; Shirotani T; Araki E
    Diabetes Res Clin Pract; 2002 Apr; 56(1):13-8. PubMed ID: 11879716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-transplant diabetic ketoacidosis--a possible consequence of immunosuppression with calcineurin inhibiting agents: a case series.
    Yoshida EM; Buczkowski AK; Sirrs SM; Elliott TG; Scudamore CH; Levin A; Tildesley HD; Landsberg DN
    Transpl Int; 2000; 13(1):69-72. PubMed ID: 10743693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic ketoacidosis associated with tacrolimus in solid organ transplant recipients.
    Masood MQ; Rabbani M; Jafri W; Habib M; Saleem T
    J Pak Med Assoc; 2011 Mar; 61(3):288-90. PubMed ID: 21465949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus-Induced Diabetic Ketoacidosis and Effect of Switching to Everolimus: A Case Report.
    Tuğcu M; Kasapoğlu U; Boynueğri B; Can Ö; Gökçe AM; Ruhi Ç; Titiz M
    Transplant Proc; 2015 Jun; 47(5):1528-30. PubMed ID: 26093759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic ketoacidosis associated with acute pancreatitis in a heart transplant recipient treated with tacrolimus.
    Im MS; Ahn HS; Cho HJ; Kim KB; Lee HY
    Exp Clin Transplant; 2013 Feb; 11(1):72-4. PubMed ID: 23075084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic ketoacidosis in a child on FK506 immunosuppression after a liver transplant.
    Keshavarz R; Mousavi MA; Hassani C
    Pediatr Emerg Care; 2002 Feb; 18(1):22-4. PubMed ID: 11862133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus-induced diabetic ketoacidosis with subsequent rapid recovery of endogenous insulin secretion after cessation of tacrolimus: A case report with review of literature.
    Maruyama K; Chujo D
    Medicine (Baltimore); 2019 Sep; 98(36):e16992. PubMed ID: 31490380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrolimus-induced acute pancreatitis and diabetic ketoacidosis (DKA) in pediatric kidney transplant recipient.
    Mazumder MA; Gulati S; Narula AS; Shehwar D; Mir IM
    Pediatr Transplant; 2022 Mar; 26(2):e14194. PubMed ID: 34854174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic ketoacidosis following development of de novo diabetes in renal transplant recipient associated with tacrolimus.
    Ersoy A; Ersoy C; Tekce H; Yavascaoglu I; Dilek K
    Transplant Proc; 2004 Jun; 36(5):1407-10. PubMed ID: 15251345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case showing complete insulin independence after severe diabetic ketoacidosis associated with tacrolimus treatment.
    Cho YM; Park KS; Jung HS; Kim YS; Kim SY; Lee HK
    Diabetes Care; 2002 Sep; 25(9):1664. PubMed ID: 12196452
    [No Abstract]   [Full Text] [Related]  

  • 11. Tacrolimus-Induced Diabetic Ketoacidosis After Allogeneic Bone Marrow Transplant.
    Solmaz S; Gökgöz Z; Gereklioğlu Ç; Yeral M; Boğa C; Özdoğu H
    Exp Clin Transplant; 2017 Dec; 15(6):702-703. PubMed ID: 26643544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rare but important adverse effect of tacrolimus in a heart transplant recipient: diabetic ketoacidosis.
    Öztürk Z; Gönç EN; Akcan L; Kesici S; Ertuğrul İ; Bayrakçı B
    Turk J Pediatr; 2015; 57(5):533-5. PubMed ID: 27411426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrolimus induced diabetic ketoacidosis in nephrotic syndrome.
    Sarkar S; Mondal R; Nandi M; Das AK
    Indian J Pediatr; 2013 Jul; 80(7):596-7. PubMed ID: 22660906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New-onset diabetes mellitus presenting with diabetic ketoacidosis after pediatric liver transplantation.
    Dehghani SM; Nikeghbalian S; Eshraghian A; Haghighat M; Imanieh MH; Bahador A; Kazemi K; Malek-Hosseini SA
    Pediatr Transplant; 2009 Aug; 13(5):536-9. PubMed ID: 19207220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperglycemic hyperosmolar state in an adolescent with type 1 diabetes mellitus.
    Watanabe S; Kido J; Ogata M; Nakamura K; Mizukami T
    Endocrinol Diabetes Metab Case Rep; 2019 Mar; 2019():. PubMed ID: 30836328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes as a complication of tacrolimus (FK506) in pediatric renal transplant patients.
    Furth S; Neu A; Colombani P; Plotnick L; Turner ME; Fivush B
    Pediatr Nephrol; 1996 Feb; 10(1):64-6. PubMed ID: 8611359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes mellitus and islet cell specific autoimmunity as adverse effects of immunsuppressive therapy by FK506/tacrolimus.
    Lohmann T; List C; Lamesch P; Kohlhaw K; Wenzke M; Schwarz C; Richter O; Hauss J; Seissler J
    Exp Clin Endocrinol Diabetes; 2000; 108(5):347-52. PubMed ID: 10989953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin in an HIV-infected patient with protease inhibitor-induced diabetic ketoacidosis.
    Hughes CA; Taylor GD
    Ann Pharmacother; 2001; 35(7-8):877-80. PubMed ID: 11485138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-transplant diabetes with anti-glutamic acid decarboxylase antibody during tacrolimus therapy.
    Yoshioka K; Sato T; Okada N; Ishii T; Imanishi M; Tanaka S; Kim T; Sugimoto T; Fujii S
    Diabetes Res Clin Pract; 1998 Nov; 42(2):85-9. PubMed ID: 9886744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive neurological disease induced by tacrolimus in a renal transplant recipient: case presentation.
    Chegounchi M; Hanna MG; Neild GH
    BMC Nephrol; 2006 Mar; 7():7. PubMed ID: 16573841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.